Clinical Evidence for GLP-1 Receptor Agonists in Alzheimer’s Disease: A Systematic Review
Background: Alzheimer’s disease (AD) is the most common cause of dementia. While preclinical studies have shown benefits of glucagon-like peptide 1 receptor agonists (GLP-1 RA) in targeting core AD pathology, clinical studies are limited. Objective: A systematic review was performed to evaluate GLP-...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
SAGE Publishing
2024-05-01
|
| Цуврал: | Journal of Alzheimer's Disease Reports |
| Онлайн хандалт: | https://doi.org/10.3233/ADR-230181 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|